BIRD—Evidence to Decision Framework Meeting for Ivermectin’s Efficacy

BIRD—Evidence to Decision Framework Meeting for Ivermectin’s Efficacy

Over the weekend, the British Ivermectin Recommendation Development (BIRD) panel included dozens of multinational scientists and doctors discussing the mounting data points and evidence supporting the use of Ivermectin for COVID-19 cases. The large, diverse group reviewed the evidence associated with ivermectin to potentially prevent and treat COVID-19, with a goal of reaching a consensus and making recommendations for further investigation and/or use. The group issued sweeping recommendations for the immediate global use of ivermectin. The findings are now in the hands of the World Health Organization (WHO). Dr. Tess Lawrie Director, The Evidence-Based Medicine Consultancy Ltd., has contributed ongoing to the scientific discussion involving growing evidence for use of Ivermectin as a treatment for COVID-19. 

This effort is part of a growing movement representing scientists, researchers, physicians, patients advocacy and others increasingly convinced that the weight of the data from dozens of clinical trials and associated meta-analyses has at least 65 international experts convinced the time for action is now. Follow the link to the committee event this past Saturday.

Responses

    1. Extraordinary analysis. I have been saying this to my friends who ask whether I’m going to get one of the (potentially) 3 vaccines available. My answer to them is that at least till one or more of the vaccines is proven, after massive REAL WORLD deployment, to be both safe AND effective, I will rely on the I-protocol to protect myself and family. Having an effective, safe, inexpensive, readily available therapeutic agent beats vaccine for safety, costs ,and efficacy, as well as probable compliance.